TRAIL Is Associated with Impaired Regulation of CD4+CD25- T Cells by Regulatory T Cells in Patients with Rheumatoid Arthritis

被引:35
作者
Xiao, Hong [2 ]
Wang, Shun [3 ]
Miao, RunSheng [1 ]
Kan, WuSheng [1 ]
机构
[1] Fourth Hosp Wuhan, Dept Orthoped, Wuhan 430000, Peoples R China
[2] Wuhan 1 Hosp, Wuhan 430000, Peoples R China
[3] Wuhan 1 Hosp, Dept Lab Med, Wuhan 430000, Peoples R China
关键词
Apoptosis; regulatory T cells; rheumatoid arthritis; TRAIL; cytokine; IMMUNOLOGICAL SELF-TOLERANCE; COLLAGEN-INDUCED ARTHRITIS; APOPTOSIS-INDUCING LIGAND; PERIPHERAL-BLOOD; EXPRESSION; DISEASE; POPULATION; RECEPTOR; ONSET; CD25;
D O I
10.1007/s10875-011-9559-x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Thirty-five rheumatoid arthritis (RA) patients and 27 healthy volunteers were enrolled in the study. Regulatory T (Treg) cell numbers were significantly reduced in RA patients. RA Treg cells exhibited an impaired capacity to inhibit proliferation and cytokine secretion of autologous T effector (Teff) cells. However, the crossover experiments further indicated that this impaired suppression was due to resistance of Teff cells but not to an intrinsic defect of Treg cells in RA patients. RA Teff cells showed a higher expression of membrane tumor necrosis factor-related apoptosis-inducing ligand and secreted more soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). TRAIL could induce apoptosis in Treg cells. Neutralization of TRAIL restored the regulation of Teff by Treg in RA patients. In summary, our data suggest that reduced peripheral Treg cell numbers and an increased resistance of Teff cells to suppression by Treg cells were present in RA patients, and TRAIL may be an underlying mechanism for the impaired regulation of Teff cells by Treg cells.
引用
收藏
页码:1112 / 1119
页数:8
相关论文
共 25 条
  • [1] Recent developments in the immunobiology of rheumatoid arthritis
    Andersson, Anna K.
    Li, Ching
    Brennan, Fionula M.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2008, 10 (02)
  • [2] CD4+CD25high regulatory cells in human peripheral blood
    Baecher-Allan, C
    Brown, JA
    Freeman, GJ
    Hafler, DA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1245 - 1253
  • [3] Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
    Brusko, Todd M.
    Putnam, Amy L.
    Bluestone, Jeffrey A.
    [J]. IMMUNOLOGICAL REVIEWS, 2008, 223 : 371 - 390
  • [4] Cope AP, 2007, CLIN EXP RHEUMATOL, V25, pS4
  • [5] CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis
    de Kleer, IM
    Wedderburn, LR
    Taams, LS
    Patel, A
    Varsani, H
    Klein, M
    de Jager, W
    Pugayung, G
    Giannoni, F
    Rijkers, G
    Albani, S
    Kuis, W
    Prakken, B
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (10) : 6435 - 6443
  • [6] CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis
    Han, Guang Ming
    O'Neil-Andersen, Nancy J.
    Zurier, Robert B.
    Lawrence, David A.
    [J]. CELLULAR IMMUNOLOGY, 2008, 253 (1-2) : 92 - 101
  • [7] Kayagaki N, 1999, J IMMUNOL, V162, P2639
  • [8] Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis
    Kelchtermans, H.
    Geboes, L.
    Mitera, T.
    Huskens, D.
    Leclercq, G.
    Matthys, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (05) : 744 - 750
  • [9] Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis:: an important factor in pathogenesis, counter-regulated by endogenous IFN-γ
    Kelchtermans, H
    De Klerck, B
    Mitera, T
    Van Balen, M
    Bullens, D
    Billiau, A
    Leclercq, G
    Matthys, P
    [J]. ARTHRITIS RESEARCH & THERAPY, 2005, 7 (02) : R402 - R415
  • [10] Up-Regulation of Cytokines and Chemokines Predates the Onset of Rheumatoid Arthritis
    Kokkonen, Heidi
    Soderstrom, Ingegerd
    Rocklov, Joacim
    Hallmans, Goran
    Lejon, Kristina
    Dahlqvist, Solbritt Rantapaa
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (02): : 383 - 391